EGF improves recovery following relief of unilateral ureteral obstruction in the neonatal rat.
OBJECTIVE
Renal epidermal growth factor (EGF) is suppressed by unilateral ureteral obstruction (UUO), and we reported previously that exogenous EGF attenuates renal injury due to UUO in the neonatal rat. In this study, we wished to determine whether administration of epidermal growth factor (EGF) improves long-term renal cellular recovery after relief of obstruction.


METHODS
One ureter of 1 day-old rats was occluded or sham-operated, and rats received daily injections of EGF, 0.1 mg./kg., or saline for the following 7 days. Five days following UUO, the obstruction was removed. Kidneys were removed 28 days following release of UUO or sham operation, and processed for histomorphometry and immunohistochemistry.


RESULTS
Kidney weight and the number of glomeruli were reduced in the postobstructed kidney regardless of administration of EGF. However, EGF reduced tubular vimentin by 36% and clusterin expression by 70% (markers of tubular injury), and decreased tubular atrophy by 50% in the postobstructed kidney compared with saline-treated rats. EGF also reduced interstitial alpha-smooth muscle actin and interstitial collagen deposition by 50% in the postobstructed kidney.


CONCLUSIONS
Short-term administration of EGF markedly attenuates both tubular and interstitial injury one month following the release of UUO in the neonatal rat. This suggests therapeutic potential for targeted delivery of growth factors to optimize recovery after release of urinary tract obstruction.
Chevalier
R L
RL
Department of Pediatrics, University of Virginia, Charlottesville 22908, USA.
Goyal
S
S
Thornhill
B A
BA
D000818:Animals; D000831:Animals, Newborn; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D007668:Kidney / Q000737:chemistry / Q000187:drug effects* / Q000254:growth & development / Q000473:pathology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014517:Ureteral Obstruction
D004815:Epidermal Growth Factor